{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:06:56Z","timestamp":1761102416556,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jss.2020.06.029","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:22:30Z","timestamp":1595463750000},"page":"267-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Expectations of Surveillance for Non-BRCA Gene Mutation Carriers at Increased Risk for Breast Cancer"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0452-0965","authenticated-orcid":false,"given":"Rachel","family":"Caskey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9821-3324","authenticated-orcid":false,"given":"Brandon","family":"Singletary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareen","family":"Ayre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Krontiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael B.","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2020.06.029_bib1","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.1251827","article-title":"Two decades after BRCA: setting paradigms in personalized cancer care and prevention","volume":"343","author":"Couch","year":"2014","journal-title":"Science"},{"issue":"suppl 2","key":"10.1016\/j.jss.2020.06.029_bib2","first-page":"AB054","article-title":"Overview of multi-gene panels for hereditary cancer","volume":"3","author":"Dalton","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jss.2020.06.029_bib3","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/bcr3062","article-title":"CHEK2 contribution to hereditary breast cancer in non-BRCA families","volume":"13","author":"Desrichard","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jss.2020.06.029_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jss.2020.06.029_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2\u22171100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Oldenburg","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jss.2020.06.029_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jss.2020.06.029_bib7","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2020.06.029_bib8","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.3747\/co.25.3707","article-title":"Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review","volume":"25","author":"Jerzak","year":"2018","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jss.2020.06.029_bib9","first-page":"331","article-title":"Current perspectives on CHEK2 mutations in breast cancer","volume":"9","author":"Apostolou","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jss.2020.06.029_bib10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jss.2020.06.029_bib11","first-page":"484","article-title":"PALB2 (partner and localizer of BRCA2)","volume":"22","author":"Hanenberg","year":"2018","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"10.1016\/j.jss.2020.06.029_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"Genetic\/familial high-risk assessment: breast and ovarian, featured updates to the NCNN guidelines","volume":"15","author":"Daly","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jss.2020.06.029_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12911-019-0873-1","article-title":"The impact of an online patient decision aid for women with breast cancer considering immediate breast reconstruction: study protocol of a multicenter randomized control trial","volume":"19","author":"ter Stege","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jss.2020.06.029_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.05.066","article-title":"Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1\/2 mutation carriers","volume":"22","author":"Van Roosmalen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.06.029_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","volume":"121","author":"Metcalfe","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2020.06.029_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heiboer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2020.06.029_bib17","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1245\/s10434-017-5976-2","article-title":"Differences among a modern cohort of BRCA mutation carriers choosing bilateral prophylactic mastectomies compared to breast surveillance","volume":"24","author":"Gilbert","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2020.06.029_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/pon.904","article-title":"The psychological impact of mammographic screening. A systematic review","volume":"14","author":"Brett","year":"2005","journal-title":"Psychooncology"},{"key":"10.1016\/j.jss.2020.06.029_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/000313481608200943","article-title":"Malignancy rate, number needed to treat, and positive predictive value for breast MRI","volume":"82","author":"Kennedy","year":"2016","journal-title":"Am Surg"},{"key":"10.1016\/j.jss.2020.06.029_bib20","first-page":"1136","article-title":"MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicenter, randomised, control trial","volume":"20","author":"Saadatmand","year":"2019","journal-title":"Oncology"},{"key":"10.1016\/j.jss.2020.06.029_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening for women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2020.06.029_bib22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jama.2012.388","article-title":"Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk","volume":"307","author":"Berg","year":"2012","journal-title":"JAMA"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:50:59Z","timestamp":1758379859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480420304224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"alternative-id":["S0022480420304224"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2020.06.029","relation":{},"ISSN":["0022-4804"],"issn-type":[{"type":"print","value":"0022-4804"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expectations of Surveillance for Non-BRCA Gene Mutation Carriers at Increased Risk for Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2020.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}